Salesforce has priced an underwritten offering of $25 billion in senior notes.

Salesforce (NYSE: CRM), the world's #1 AI CRM, today announced that it has priced an underwritten offering (the "offering") in aggregate principal amount of $25 billion in senior notes (the "notes"). The offering is expected to close on March 13, 2026, subject to the satisfaction of customary closing conditions.

Salesforce intends to use all of the net proceeds from the offering, after deducting underwriting discounts and estimated offering expenses payable by Salesforce, to repurchase shares of Salesforce common stock pursuant to certain accelerated share repurchase ("ASR") agreements that Salesforce entered into with certain financial institution counterparties immediately following the pricing of the offering, which provide for the repurchase by Salesforce of an aggregate of $25 billion of shares of Salesforce common stock. The prepayment and initial share delivery under the ASR transactions is expected to occur on March 16, 2026.

J.P. Morgan Securities LLC, BofA Securities, Inc., Barclays Capital Inc., Citigroup Global Markets Inc. and Wells Fargo Securities, LLC are serving as joint book-running managers for the offering of the notes.

Salesforce has filed a registration statement (including a prospectus) and a preliminary prospectus supplement with the U.S. Securities and Exchange Commission for the offering to which this communication relates. Copies of the prospectus supplement, when available, and the accompanying base prospectus related to the offering may be obtained by contacting J.P. Morgan Securities LLC at 1-212-834-4533 (collect); BofA Securities, Inc. toll-free at 1-800-294-1322; Barclays Capital Inc. toll-free at 1-888-603-5847; Citigroup Global Markets Inc. toll-free at 1-800-831-9146; or Wells Fargo Securities, LLC toll-free at 1-800-645-3751. Alternatively, investors may get these documents for free by visiting EDGAR on the SEC website at http://www.sec.gov/.

http://www.datamonitor.com
Republication or redistribution, including by framing or similar means,
is expressly prohibited without prior written consent. Datamonitor shall 
not be liable for errors or delays in the content, or for any actions 
taken in reliance thereon
COMTEX_478959312/2227/2026-05-11T21:13:51